MHRA publishes its first monthly safety bulletin for medical devices and medicines
Written by: Manuel Mateos CEO and Regulatory Affairs Director, CMC Medical Devices & Drugs S.L.
In March 2025, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) launched the first issue of its new monthly safety bulletin, a step forward in making critical safety information more transparent and easier to access.
This initiative is particularly important for manufacturers operating in the UK, where keeping up to date with regulatory changes is essential for maintaining compliance and ensuring patient safety.
A new approach to safety communication
Following feedback from healthcare professionals, the MHRA identified a clear need for more accessible and centralized updates. With the launch of this bulletin, all relevant safety information, such as device notices, medicine updates, patient alerts, and product recalls, is now published in a single, easy-to-read format, every month.
The goal? To simplify the regulatory landscape and make it easier for stakeholders to stay compliant.
Why it matters to medical device manufacturers
If you’re a medical device manufacturer with products on the UK market, these bulletins are more than just updates, they’re essential tools for ensuring ongoing compliance with MHRA expectations.
Being aware of recalls, safety communications, and regulatory news helps you avoid delays, manage risks, and stay aligned with legal requirements.
Do you need support in the UK market?
The UK regulatory system can be complex, and recent changes like this bulletin make staying informed even more critical.
Looking for a reliable UK Responsible Person?
👉 Check out our UK RP service
Conclusions
The MHRA’s new monthly safety bulletin is a step toward better transparency and safer market practices.
Staying informed has never been easier, and with the right partner, staying compliant can be just as smooth.
Contact us to learn how we can support your market access and regulatory strategy in the UK.
